1 | Cancer | 0.91% | |
2 | Study | 0.87% | |
3 | Health | 0.82% | |
4 | New | 0.66% | |
5 | Medicina | 0.55% | |
6 | COVID-19 | 0.45% | |
7 | Disease | 0.38% | |
8 | Patients | 0.38% | |
9 | Case | 0.35% | |
10 | Report | 0.34% | |
11 | Risk | 0.34% | |
12 | Covid | 0.33% | |
13 | COVID | 0.31% | |
14 | May | 0.29% | |
15 | Brain | 0.28% | |
16 | Salud | 0.26% | |
17 | News | 0.25% | |
18 | BMC | 0.24% | |
19 | Hospital | 0.24% | |
20 | HIV | 0.24% | |
21 | Dengue | 0.22% | |
22 | Africa | 0.22% | |
23 | Vaccine | 0.22% | |
24 | Breast | 0.21% | |
25 | Heart | 0.21% | |
26 | Horoscopo | 0.2% | |
27 | County | 0.2% | |
28 | Abril | 0.2% | |
29 | Research | 0.18% | |
30 | AI | 0.18% | |
31 | Patient | 0.18% | |
32 | Human | 0.17% | |
33 | Treatment | 0.17% | |
34 | Liver | 0.16% | |
35 | CDC | 0.16% | |
36 | Acute | 0.16% | |
37 | World | 0.15% | |
38 | Care | 0.15% | |
39 | Linked | 0.14% | |
40 | Food | 0.14% | |
41 | China | 0.14% | |
42 | April | 0.14% | |
43 | Covid-19 | 0.14% | |
44 | Prostate | 0.14% | |
45 | Rare | 0.14% | |
46 | Medicine | 0.14% | |
47 | Syndrome | 0.14% | |
48 | Dieta | 0.14% | |
49 | Saude | 0.13% | |
50 | Parkinsons | 0.13% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
Fibrilacion atrial: Puede ser necesario el uso de marcapasos y ablacion del sistema de conduccion
Medicina y Salud Publica
2024-04-20 05:55:00
Computerized stewardship prompt linked to improved antibiotic prescribing in two trials
University of Minnesota Twin Cities
2024-04-20 05:23:08
Behind the CheckMate-77T Trial of a Nivolumab-Based Regimen in NSCLC
Targeted Oncology
2024-04-20 04:03:36
Cureus
2024-04-19 20:25:02
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
AJMC.com Managed Markets Network
2024-04-19 03:34:45
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
BioSpace
2024-04-19 03:14:13
Trial for immunotherapy drug shows promise for aggressive breast cancer
Medical Xpress
2024-04-19 02:24:04
Adjuvant Pembrolizumab Offers Improved OS in KEYNOTE-564 Trial of ccRCC
Targeted Oncology
2024-04-19 01:10:40
Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine
MarketWatch
2024-04-18 23:23:00
Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson's patients - News
Medical.Net
2024-04-18 23:13:00
New trials show promise for immune checkpoint blockers in early-stage lung cancer - News
Medical.Net
2024-04-18 21:23:00
Patient Care Online
2024-04-18 19:11:13